TickerFactsScreenerDevelopers

Axsome Therapeutics, Inc. (AXSM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$5.67M2015: -$9.20M2016: -$27.54M2017: -$27.16M2018: -$32.85M2019: -$67.25M2020: -$99.14M2021: -$124.71M2022: -$179.80M2023: -$231.82M2024: -$280.56M2025: -$166.76M-$166.76M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$166.76M+40.6%
2024-$280.56M-21.0%
2023-$231.82M-28.9%
2022-$179.80M-44.2%
2021-$124.71M-25.8%
2020-$99.14M-47.4%
2019-$67.25M-104.7%
2018-$32.85M-20.9%
2017-$27.16M+1.4%
2016-$27.54M-199.5%
2015-$9.20M-62.1%
2014-$5.67M—